Pluristem Therapeutics To Collaborate With Israel In Treatment Of Burn Injuries

(RTTNews) - Pluristem Therapeutics Inc. (PSTI) announced the receipt of a joint grant awarded by the Israeli Ministry of Defense and the Israel Innovation Authority for the development of the company's PLX cells for the treatment of burn injuries.

The project entails collaboration between the Company, the Israeli Defense Forces (IDF) medical corps and professionals who specialize in burn injuries from Israeli hospitals.

The provision of the grant is based on Pluristem's previously published clinical trial data, which demonstrated successful regeneration of muscle tissue and blood vessels as a result of PLX administration, as well as the anti-inflammatory ability of the cells.

The company noted that proceeds from the grant will support studies of the effects of PLX cells in expediting burn wound healing.